These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
270 related items for PubMed ID: 18952308
41. Feasibility of involved-field conformal radiotherapy for cervical and upper-thoracic esophageal cancer. Ma JB, Song YP, Yu JM, Zhou W, Cheng EC, Zhang XQ, Kong L. Onkologie; 2011; 34(11):599-604. PubMed ID: 22104156 [Abstract] [Full Text] [Related]
42. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck. McCloskey SA, Jaggernauth W, Rigual NR, Hicks WL, Popat SR, Sullivan M, Mashtare TL, Khan MK, Loree TR, Singh AK. Am J Clin Oncol; 2009 Dec; 32(6):587-91. PubMed ID: 19581794 [Abstract] [Full Text] [Related]
44. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer. Miyoshi N, Yano M, Takachi K, Kishi K, Noura S, Eguchi H, Yamada T, Miyashiro I, Ohue M, Ohigashi H, Sasaki Y, Ishikawa O, Doki Y, Imaoka S. J Surg Oncol; 2009 Apr 01; 99(5):302-6. PubMed ID: 19170110 [Abstract] [Full Text] [Related]
45. Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma. Tachimori Y, Kanamori N, Uemura N, Hokamura N, Igaki H, Kato H. J Thorac Cardiovasc Surg; 2009 Jan 01; 137(1):49-54. PubMed ID: 19154902 [Abstract] [Full Text] [Related]
47. Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis. Chang DT, Chapman C, Shen J, Su Z, Koong AC. Am J Clin Oncol; 2009 Aug 01; 32(4):405-10. PubMed ID: 19415029 [Abstract] [Full Text] [Related]
48. Elective nodal irradiation versus involved-field irradiation for stage II-IV cervical esophageal squamous cell carcinoma patients undergoing definitive concurrent chemoradiotherapy: a retrospective propensity study with 8-year survival outcomes. Wang J, Wu Y, Zhang W, Chen Y, Liu Q, Jing S, Zhang J, Wu F, Wang J, Qiao X. Radiat Oncol; 2023 Aug 28; 18(1):142. PubMed ID: 37641149 [Abstract] [Full Text] [Related]
49. Incidental irradiation of mediastinal and hilar lymph node stations during 3D-conformal radiotherapy for non-small cell lung cancer. Kepka L, Bujko K, Zolciak-Siwinska A, Garmol D. Acta Oncol; 2008 Aug 28; 47(5):954-61. PubMed ID: 17899455 [Abstract] [Full Text] [Related]
50. [The patterns and prognostic factors of abdominal lymph node metastasis in patients with the middle thoracic esophageal squamous cell carcinoma]. Wang Z, Liu XY, Liu FY. Zhonghua Wai Ke Za Zhi; 2008 Dec 01; 46(23):1800-3. PubMed ID: 19094790 [Abstract] [Full Text] [Related]
51. Relation between elective nodal failure and irradiated volume in non-small-cell lung cancer (NSCLC) treated with radiotherapy using conventional fields and doses. Sanuki-Fujimoto N, Sumi M, Ito Y, Imai A, Kagami Y, Sekine I, Kunitoh H, Ohe Y, Tamura T, Ikeda H. Radiother Oncol; 2009 Jun 01; 91(3):433-7. PubMed ID: 19167118 [Abstract] [Full Text] [Related]
53. Size does matter: can we reduce the radiotherapy field size for selected cases of anal canal cancer undergoing chemoradiation? Crowley C, Winship AZ, Hawkins MA, Morris SL, Leslie MD. Clin Oncol (R Coll Radiol); 2009 Jun 01; 21(5):376-9. PubMed ID: 19282157 [Abstract] [Full Text] [Related]
57. Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma? Chen G, Wang Z, Liu XY, Liu FY. Ann Thorac Surg; 2009 Jun 01; 87(6):1697-702. PubMed ID: 19463580 [Abstract] [Full Text] [Related]